£250k grant to fund immunotherapy research for prostate cancer
Researchers from the University of Glasgow have received a grant worth over £250,000 from health charity, Prostate Cancer UK, to explore an innovative immunotherapy treatment designed to help patients with advanced prostate cancer.
The grants have been awarded as part of the charity’s £3 million Research Innovation Awards scheme following a competitive process and detailed assessment from international experts. The scheme encourages researchers from across the UK to develop forward thinking, ambitious research proposals which challenge the status quo to help fight prostate cancer.
The study, led by Professor Stephen Tait at the Cancer Research UK Beatson Institute, aims to develop a new therapy that kills cancer cells using the body’s own immune system.
Professor Tait said: “Immunotherapy is a really exciting development in the fight against cancer which uses the body’s own natural defences to attack the disease. We already know this method works well in other cancers, and this funding gives us the chance to find out whether it can also help men whose prostate cancer is currently incurable.
First published: 1 August 2019